%0 Conference Paper %F Poster %T Assessment of the French colistin action plan %+ Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE) %+ Laboratoire de Ploufragan-Plouzané-Niort [ANSES] %+ Université de Lyon %+ Laboratoire de Lyon [ANSES] %+ Unité Epidémiologie et Appui à la Surveillance (EAS) %+ Laboratoire de Fougères - ANSES %+ Institut du Porc (IFIP) %+ Agence nationale du médicament vétérinaire (ANMV) %A Coz, Elsa %A Jouy, Eric %A Cazeau, Géraldine %A Jarrige, Nathalie %A Perrin-Guyomard, Agnes %A Hemonic, Anne %A Poissonnet, Alexandre %A Urban, Delphine %A Chevance, Anne %A Delignette-Muller, Marie Laure %A Chauvin, Claire %< avec comité de lecture %B Third International Conference AACTING: Quantification, Benchmarking and Stewardship of Veterinary Antimicrobial Usage %C Hannover, Germany, Germany %8 2022-05-05 %D 2022 %K Veterinary antimicrobial usage %K Colistin %K France %Z Life Sciences [q-bio]Conference poster %X The discovery of the plasmid resistance gene to colistin mcr-1 in 2015, profoundly changed the way this widely used molecule in veterinary medicine in France was considered. National management measures have been set up to reduce its use in animals, in line with European recom-mendations. Two objectives were defined: that of the AMEG in 2016, to reach a consumption of less than 5mg/kg in 3 to 4 years and that defined by the Ecoantibio2 national plan of a 50% reduction in the cattle, pig and poultry sectors in 5 years compared to the 2014-2015 use. In order to assess the effectiveness of these measures, French sales, usages and resistance surveillance data were analysed. %G English %L anses-04084027 %U https://anses.hal.science/anses-04084027 %~ ANSES %~ CNRS %~ INRIA %~ UNIV-LYON1 %~ BIOENVIS %~ AGREENIUM %~ INRIA-AUT %~ VETAGRO-LBBE %~ LBBE %~ VETAGRO-SUP %~ UDL %~ UNIV-LYON %~ TEST3-HALCNRS %~ TEST4-HALCNRS %~ TEST5-HALCNRS